Addex Therapeutics Ltd
SIX:ADXN
Addex Therapeutics Ltd
Revenue
Addex Therapeutics Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Addex Therapeutics Ltd
SIX:ADXN
|
Revenue
CHf2.5m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Revenue
$69.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
129%
|
CAGR 10-Years
N/A
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Revenue
$371.2m
|
CAGR 3-Years
709%
|
CAGR 5-Years
160%
|
CAGR 10-Years
N/A
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Revenue
CHf157.6m
|
CAGR 3-Years
7%
|
CAGR 5-Years
4%
|
CAGR 10-Years
14%
|
|
Idorsia Ltd
SIX:IDIA
|
Revenue
CHf97.1m
|
CAGR 3-Years
60%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
Kuros Biosciences AG
SIX:KURN
|
Revenue
CHf33.6m
|
CAGR 3-Years
103%
|
CAGR 5-Years
116%
|
CAGR 10-Years
N/A
|
See Also
What is Addex Therapeutics Ltd's Revenue?
Revenue
2.5m
CHF
Based on the financial report for Sep 30, 2023, Addex Therapeutics Ltd's Revenue amounts to 2.5m CHF.
What is Addex Therapeutics Ltd's Revenue growth rate?
Revenue CAGR 3Y
-18%
Over the last year, the Revenue growth was 10%. The average annual Revenue growth rates for Addex Therapeutics Ltd have been -18% over the past three years .